| Luis Terceiro, RNFA | |
|
17101 Dallas Pkwy, Addison, TX 75001-7103 | |
| (254) 248-7459 | |
| Not Available |
| Full Name | Luis Terceiro |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse - Registered Nurse First Assistant |
| Location | 17101 Dallas Pkwy, Addison, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740759414 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WR0006X | Registered Nurse - Registered Nurse First Assistant | 850630 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Luis Terceiro, RNFA 17250 Dallas Pkwy, Dallas, TX 75248-1136 Ph: (254) 248-7459 | Luis Terceiro, RNFA 17101 Dallas Pkwy, Addison, TX 75001-7103 Ph: (254) 248-7459 |
News Archive
In this month's Physics World, Steve Haake, director of the Centre for Sports Engineering at Sheffield Hallam University in the UK, reveals that the men's 100 m sprint will be one event not to miss this summer.
According to a new Australian study, taking fish oil / docosahexaenoic acid (DHA) supplements during pregnancy does not appear to reduce the risk of postpartum depression of mothers or boost the language development and cognitive skills of their children.
During his lifetime, Henry G. Molaison (H.M.) was the best-known and possibly the most-studied patient of modern neuroscience. Now, thanks to the postmortem study of his brain, based on histological sectioning and digital three-dimensional construction led by Jacopo Annese, PhD, at the University of California, San Diego, scientists around the globe will finally have insight into the neurological basis of the case that defined modern studies of human memory.
The project, funded by the Ministry of Health, aims to ascertain whether timber workers exposed to the PCPs (pentachlorophenols) are dying earlier, getting cancers more often and suffering more chronic health problems, including fatigue, nausea and neuropsychological dysfunction.
They found that the anti-cancer drug imatinib mesylate — commercially known as Gleevec and produced by Novartis Pharmaceuticals — can target a gene critical to controlling the disease process. Previously, there had been no treatment and patients usually did not survive beyond three years of diagnosis. Now the treatment is undergoing clinical trials at Mayo Clinic.
› Verified 4 days ago
Viviana Lozano, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15801 Artist Way Apt 4108, Addison, TX 75001 Phone: 830-955-3961 | |
Racheal Ebangha Besong, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3925 Vitruvian Way Apt 1907, Addison, TX 75001 Phone: 386-366-3461 | |
Leticia Harley, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3925 Vitruvian Way Apt 2111, Addison, TX 75001 Phone: 972-803-7708 | |
Kyeongmi Kim, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3820 Vitruvian Way Apt 120, Addison, TX 75001 Phone: 979-900-4556 | |
Amy Henderson, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 14131 Midway Rd Ste 260, Addison, TX 75001 Phone: 662-415-9042 |